Are Analysts Bearish Accuray Incorporated (NASDAQ:ARAY) After Last Week?

April 20, 2018 - By Hazel Jackson

Accuray Incorporated (NASDAQ:ARAY) LogoInvestors sentiment decreased to 1.07 in 2017 Q4. Its down 0.16, from 1.23 in 2017Q3. It worsened, as 13 investors sold Accuray Incorporated shares while 31 reduced holdings. 18 funds opened positions while 29 raised stakes. 64.52 million shares or 1.17% more from 63.77 million shares in 2017Q3 were reported.
Advisory Service Lc has invested 0.01% in Accuray Incorporated (NASDAQ:ARAY). Ny State Common Retirement Fund invested in 0% or 72,100 shares. 126,726 are owned by Goldman Sachs Group Inc. Partner Invest Mngmt Limited Partnership reported 40,596 shares or 0.2% of all its holdings. Menta Capital Ltd Liability Co has 177,203 shares for 0.15% of their portfolio. Deutsche National Bank & Trust Ag holds 0% in Accuray Incorporated (NASDAQ:ARAY) or 181,513 shares. Lapides Asset Lc accumulated 1.81M shares or 1.69% of the stock. Winslow Evans & Crocker Inc invested 0% of its portfolio in Accuray Incorporated (NASDAQ:ARAY). Adirondack Research And Mgmt reported 251,396 shares or 0.42% of all its holdings. Sectoral Asset Mngmt stated it has 0.32% of its portfolio in Accuray Incorporated (NASDAQ:ARAY). Engineers Gate Manager Lp has 0.01% invested in Accuray Incorporated (NASDAQ:ARAY) for 34,968 shares. Menlo Advsr Ltd Co invested in 10,000 shares or 0.03% of the stock. Vanguard Gru holds 0% of its portfolio in Accuray Incorporated (NASDAQ:ARAY) for 6.50 million shares. D E Shaw Inc reported 1.35M shares stake. State Street holds 0% or 1.74 million shares.

Since April 3, 2018, it had 0 insider purchases, and 3 sales for $66,295 activity. 2,997 shares valued at $13,936 were sold by Waters Kevin on Tuesday, April 3. 8,675 shares were sold by LEVINE JOSHUA, worth $40,339 on Tuesday, April 3.

Accuray Incorporated (NASDAQ:ARAY) Ratings Coverage

Among 5 analysts covering Accuray Inc (NASDAQ:ARAY), 2 have Buy rating, 2 Sell and 1 Hold. Therefore 40% are positive. Accuray Inc had 6 analyst reports since November 2, 2017 according to SRatingsIntel. The rating was downgraded by JP Morgan on Wednesday, December 13 to “Underweight”. The firm has “Sell” rating by J.P. Morgan given on Wednesday, December 13. RBC Capital Markets maintained the shares of ARAY in report on Wednesday, January 24 with “Hold” rating. The stock has “Hold” rating by RBC Capital Markets on Thursday, November 2. Jefferies maintained the shares of ARAY in report on Tuesday, January 23 with “Buy” rating. Below is a list of Accuray Incorporated (NASDAQ:ARAY) latest ratings and price target changes.

24/01/2018 Broker: RBC Capital Markets Rating: Hold New Target: $6.0 Maintain
23/01/2018 Broker: Jefferies Rating: Buy New Target: $7.0 Maintain
13/12/2017 Broker: J.P. Morgan Rating: Sell Downgrade
13/12/2017 Broker: JP Morgan Old Rating: Neutral New Rating: Underweight Old Target: $6 Downgrade
30/11/2017 Broker: Lake Street Rating: Buy New Target: $10 Initiates Coverage On
02/11/2017 Broker: RBC Capital Markets Rating: Hold New Target: $5.0 Maintain

The stock increased 0.97% or $0.049 during the last trading session, reaching $5.099. About 36,207 shares traded. Accuray Incorporated (NASDAQ:ARAY) has risen 2.08% since April 20, 2017 and is uptrending. It has underperformed by 9.47% the S&P500.

Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company has market cap of $434.91 million. The firm offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. It currently has negative earnings. The CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally.

Accuray Incorporated (NASDAQ:ARAY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.